New Key Statistics Module, Z-Score and F-Score
SZSE:301211 Key Ratios
Market Cap ¥ M | 5,261.76 |
Enterprise Value ¥ M | 3,444.95 |
P/E(ttm) | 30.45 |
PE Ratio without NRI | 31.66 |
Forward PE Ratio | -- |
Price/Book | 2.20 |
Price/Sales | 8.72 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | 62.57 |
Payout Ratio % | 0.69 |
Revenue (TTM) ¥ M | 607.00 |
EPS (TTM) ¥ | 0.60 |
Beneish M-Score | -2.82 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | -2.90 |
y-y EBITDA Growth Rate % | 7.70 |
EV-to-EBIT | 17.27 |
EV-to-EBITDA | 17.27 |
PEG | -- |
Shares Outstanding M | 288.00 |
Net Margin (%) | 28.56 |
Operating Margin % | 22.75 |
Pre-tax Margin (%) | 32.77 |
Quick Ratio | 14.21 |
Current Ratio | 15.47 |
ROA % (ttm) | 6.91 |
ROE % (ttm) | 7.42 |
ROIC % (ttm) | 22.48 |
Dividend Yield % | 2.19 |
Altman Z-Score | 22.84 |
SZSE:301211 Number of Guru Trades
SZSE:301211 Volume of Guru Trades
Gurus Latest Trades with SZSE:301211
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
SZSE:301211 is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Hubei Biocause Heilen Pharmaceutical Co Ltd Insider Transactions
No Available Data